This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) advanced 1.30% to $9.35 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.88% to 26,635.22 and the Dow Jones Industrial Average rising 0.75% to 50,063.46.
Novavax Inc. closed 21.89% short of its 52-week high of $11.97, which the company reached on February 26th.
The stock outperformed some of its competitors Thursday, as Johnson &amp; Johnson (JNJ) rose 0.16% to $230.80, Pfizer Inc. (PFE) fell 0.81% to $25.75, and Merck &amp; Co. Inc. (MRK) fell 0.04% to $113.41.
Trading volume (4.6 M) eclipsed its 50-day average volume of 4.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 14, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-14-26 1727ET

NVAX

IBBQ

Novavax Inc. (NVAX) shares rose 1.30% to $9.35 on a strong trading day, outperforming competitors like Johnson & Johnson (up 0.16%), while Pfizer and Merck saw declines. The NASDAQ Composite Index increased by 0.88% and the Dow Jones by 0.75%. Novavax remains 21.89% below its 52-week high of $11.97 reached on February 26. Trading volume was 4.6 million, surpassing the 50-day average of 4.4 million.

MarketWatch Automated

Novavax

Invesco Nasdaq Biotechnology ETF

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

Ark Genomic Revolution ETF

iShares Biotechnology ETF

Direxion S&P Biotech Bull 3X

NASDAQ Composite Index

Dow Jones Industrial Average

Johnson & Johnson

Pfizer

Merck

Factset Research

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day